SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-030824
Filing Date
2022-11-07
Accepted
2022-11-07 16:15:23
Documents
16
Period of Report
2022-11-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 83105
2 ex10-1.htm EX-10.1 581562
3 ex10-2.htm EX-10.2 440878
4 ex10-3.htm EX-10.3 62332
5 ex10-4.htm EX-10.4 40604
  Complete submission text file 0001493152-22-030824.txt   1592634

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE orgs-20221104.xsd EX-101.SCH 3230
7 XBRL LABEL FILE orgs-20221104_lab.xml EX-101.LAB 34916
8 XBRL PRESENTATION FILE orgs-20221104_pre.xml EX-101.PRE 22791
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3619
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38416 | Film No.: 221365630
SIC: 2834 Pharmaceutical Preparations